Concerns growing over adverse effects of co-marketing with multinational firms

Published: 2012-06-04 06:58:00

Updated: 2012-06-04 06:58:00

There are worries that Korean drug firms’ co-marketing strategy with foreign firms could result in decreasing investments in research and development, which is considered a future growth engine for the country’s pharmaceutical industry.

“The co-marketing or co-promotion strategy to sell origin...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK